Enerpac Tool Group Corp. Fiscal 2022 Form 10-K Summary
Business context and reporting period
Enerpac Tool Group Corp. is a global industrial tools and services company serving customers in more than 100 countries. Its principal reportable segment, Industrial Tools & Services (IT&S), designs, manufactures and distributes hydraulic and mechanical tools, heavy-lifting solutions, and related services and rentals. Cortland Industrial and Cortland Medical are reported in the Other segment. The former Engineered Components & Systems business remains classified as discontinued operations.
The filing covers the fiscal year ended August 31, 2022, corresponding to the reported 2022 fourth quarter and full fiscal year. The financial statements were audited by Ernst & Young LLP, which issued unqualified opinions on the financial statements and internal control over financial reporting.
Financial performance and key metrics
| Metric | Fiscal 2022 | Fiscal 2021 | Change |
|---|---|---|---|
| Net sales | $571.2 million | $528.7 million | +8% |
| Gross profit | $265.4 million | $243.2 million | +9% |
| Gross margin | 46.4% | 46.0% | Broadly stable |
| Operating profit | $30.7 million | $51.1 million | -40% |
| Operating margin | 5.4% | 9.7% | Down 4.3 points |
| Net earnings from continuing operations | $19.6 million | $40.2 million | -51% |
| Net earnings, including discontinued operations | $15.7 million | $38.1 million | -59% |
| Diluted EPS from continuing operations | $0.33 | $0.67 | Down $0.34 |
| Cash flow from continuing operations | $52.2 million | $54.9 million | -5% |
- Core sales increased 11%, excluding foreign exchange and recent acquisitions or divestitures. Foreign currency translation reduced reported sales by approximately $15 million, or 3%.
- Product sales increased to $454.1 million from $411.9 million; service and rental sales were $117.1 million, essentially flat with the prior year.
- IT&S sales increased 7% to $527.3 million, while IT&S operating profit declined 4% to $78.7 million. IT&S operating margin fell to 14.9% from 16.6%.
- Pricing actions and productivity largely offset inflation in product gross margins, but service margins declined because of lower utilization, the Russia-Ukraine conflict and service mix.
- Cash and cash equivalents were $120.7 million at year-end, including $118.7 million held by foreign subsidiaries. Net primary working capital was $118 million, or 20% of sales.
- Capital expenditures were $8.4 million, compared with $12.0 million in fiscal 2021. Depreciation and amortization was $19.6 million.
- Goodwill and other intangible assets totaled approximately $299.5 million, or 40% of total assets. Goodwill was $257.9 million after a $1.3 million Cortland Industrial impairment charge.
Debt, liquidity and capital allocation
- Total debt was $204.0 million at August 31, 2022, consisting primarily of $200 million drawn on the revolving credit facility and $4 million of swingline borrowings.
- The company reported approximately $190.8 million of available revolving capacity and compliance with its debt covenants at year-end.
- Financing activities used $52.2 million of cash, including $75.1 million for share repurchases and $60 million of revolving debt repayments, partially offset by $85 million of new borrowings.
- The company repurchased 3.76 million shares for $75.1 million during fiscal 2022 and had 6.24 million shares remaining under its authorization at year-end. It declared a $0.04-per-share dividend.
- On September 9, 2022, after year-end, the company refinanced its debt with a new $600 million senior credit facility, including a $400 million revolver and a $200 million term loan, maturing in September 2027.
Material changes versus the prior comparable period
- Sales growth accelerated as industrial markets recovered from the pandemic and the company implemented price increases. However, reported profitability declined materially because of higher SG&A, restructuring and unusual costs.
- SG&A increased by approximately $41.6 million, including ASCEND costs, bad-debt provisions, leadership transition and board-search expenses, business-review costs, and higher travel spending.
- The company recorded approximately $13.2 million for a delinquent MENAC-region agent and additional reserves for Russian receivables. The agent’s receivable represented 10.6% of outstanding accounts receivable at year-end.
- Accounts receivable increased to $106.7 million and the allowance for doubtful accounts increased to $17.5 million from $4.2 million. Inventory increased to $83.7 million from $75.3 million because of supply-chain concerns.
- Foreign currency translation produced a $46.1 million loss in other comprehensive income, contributing to a $26.3 million comprehensive loss despite positive net earnings.
- Discontinued operations generated a $3.9 million net loss in fiscal 2022, compared with a $2.1 million loss in fiscal 2021.
Guidance, outlook, risks and unusual items
- ASCEND is expected to run approximately 24 to 36 months. Management expects incremental annual operating profit of $40 million to $50 million at full implementation, with the full run rate expected as the company exits fiscal 2024 and incorporated into fiscal 2025 projections.
- Total ASCEND investment is expected to be approximately $60 million to $65 million, including third-party support, capital expenditures, restructuring and incentive costs. The company recorded approximately $17 million of ASCEND expenses in fiscal 2022.
- Restructuring costs under the updated plan are estimated at $10 million to $15 million through the fourth quarter of fiscal 2024.
- The company indefinitely suspended business in Russia following the invasion of Ukraine and sanctions. Russian-related receivables of approximately $0.5 million were fully reserved as of February 28, 2022, and Russia historically represented approximately 1% of annual sales.
- Order backlog was $72 million at August 31, 2022, up from $55 million, primarily because of strong orders and supply-chain and logistics constraints. Substantially all backlog was expected to ship within twelve months absent further supply-chain deterioration.
- Principal risks include component shortages, logistics disruptions, inflation, tariffs, commodity costs, foreign currency and interest-rate movements, cyclical industrial and oil-and-gas demand, geopolitical conflict, cybersecurity, customer and distributor credit risk, litigation, environmental liabilities, goodwill impairment and the ability to realize ASCEND benefits.
- Legal proceedings, environmental matters and a continuing Dutch investigation concerning historical Crimea-related transactions were not expected by management to have a material adverse effect, although the ultimate outcomes remain uncertain.
Most important facts for investors to verify
- Whether ASCEND delivers the projected $40 million to $50 million of annual operating profit and whether total program spending remains within the $60 million to $65 million estimate.
- Whether supply-chain constraints, inflation and service utilization continue to pressure margins and backlog conversion.
- The collectability of remaining receivables, particularly the fully reserved MENAC agent balance and other foreign distributor exposures.
- Debt levels, interest expense, covenant compliance and available liquidity under the September 2022 refinancing.
- Whether further goodwill or intangible-asset impairment charges arise, particularly for Cortland Industrial and reporting units with limited valuation headroom.
- The effect of foreign exchange changes, given the company’s substantial international sales and foreign-held cash balances.
- Future cash deployment among share repurchases, dividends, acquisitions, restructuring investment and debt reduction.